Cargando…
A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083088/ https://www.ncbi.nlm.nih.gov/pubmed/33928532 http://dx.doi.org/10.1007/s40121-021-00444-4 |
| _version_ | 1783685963352899584 |
|---|---|
| author | Ruiz-Antorán, Belén Sancho-López, Aránzazu Torres, Ferrán Fernández-Cruz, Ana |
| author_facet | Ruiz-Antorán, Belén Sancho-López, Aránzazu Torres, Ferrán Fernández-Cruz, Ana |
| author_sort | Ruiz-Antorán, Belén |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8083088 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Healthcare |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80830882021-04-30 A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Ruiz-Antorán, Belén Sancho-López, Aránzazu Torres, Ferrán Fernández-Cruz, Ana Infect Dis Ther Letter Springer Healthcare 2021-04-29 2021-09 /pmc/articles/PMC8083088/ /pubmed/33928532 http://dx.doi.org/10.1007/s40121-021-00444-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Letter Ruiz-Antorán, Belén Sancho-López, Aránzazu Torres, Ferrán Fernández-Cruz, Ana A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort |
| title | A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort |
| title_full | A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort |
| title_fullStr | A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort |
| title_full_unstemmed | A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort |
| title_short | A Response to: Letter to the Editor Regarding Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort |
| title_sort | response to: letter to the editor regarding combination of tocilizumab and steroids to improve mortality in patients with severe covid-19 infection: a spanish, multicenter, cohort |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083088/ https://www.ncbi.nlm.nih.gov/pubmed/33928532 http://dx.doi.org/10.1007/s40121-021-00444-4 |
| work_keys_str_mv | AT ruizantoranbelen aresponsetolettertotheeditorregardingcombinationoftocilizumabandsteroidstoimprovemortalityinpatientswithseverecovid19infectionaspanishmulticentercohort AT sancholopezaranzazu aresponsetolettertotheeditorregardingcombinationoftocilizumabandsteroidstoimprovemortalityinpatientswithseverecovid19infectionaspanishmulticentercohort AT torresferran aresponsetolettertotheeditorregardingcombinationoftocilizumabandsteroidstoimprovemortalityinpatientswithseverecovid19infectionaspanishmulticentercohort AT fernandezcruzana aresponsetolettertotheeditorregardingcombinationoftocilizumabandsteroidstoimprovemortalityinpatientswithseverecovid19infectionaspanishmulticentercohort AT aresponsetolettertotheeditorregardingcombinationoftocilizumabandsteroidstoimprovemortalityinpatientswithseverecovid19infectionaspanishmulticentercohort AT ruizantoranbelen responsetolettertotheeditorregardingcombinationoftocilizumabandsteroidstoimprovemortalityinpatientswithseverecovid19infectionaspanishmulticentercohort AT sancholopezaranzazu responsetolettertotheeditorregardingcombinationoftocilizumabandsteroidstoimprovemortalityinpatientswithseverecovid19infectionaspanishmulticentercohort AT torresferran responsetolettertotheeditorregardingcombinationoftocilizumabandsteroidstoimprovemortalityinpatientswithseverecovid19infectionaspanishmulticentercohort AT fernandezcruzana responsetolettertotheeditorregardingcombinationoftocilizumabandsteroidstoimprovemortalityinpatientswithseverecovid19infectionaspanishmulticentercohort AT responsetolettertotheeditorregardingcombinationoftocilizumabandsteroidstoimprovemortalityinpatientswithseverecovid19infectionaspanishmulticentercohort |